The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Antivenin is a medication made from antibodies which is used to treat certain venomous bites and stings. They are recommended only if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
The global Antivenin market was valued at US$ 959.2 million in 2023 and is anticipated to reach US$ 1277.8 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Antivenin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antivenin.
Report Scope
The Antivenin market size, estimations, and forecasts are provided in terms of sales volume (K Vials) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antivenin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antivenin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
CSL
Segment by Type
Polyvalent
Monovalent
Segment by Application
Hospitals and Clinics
Non-profit Institutions
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antivenin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antivenin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Antivenin is a medication made from antibodies which is used to treat certain venomous bites and stings. They are recommended only if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
The global Antivenin market was valued at US$ 959.2 million in 2023 and is anticipated to reach US$ 1277.8 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Antivenin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antivenin.
Report Scope
The Antivenin market size, estimations, and forecasts are provided in terms of sales volume (K Vials) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antivenin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antivenin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
CSL
Segment by Type
Polyvalent
Monovalent
Segment by Application
Hospitals and Clinics
Non-profit Institutions
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antivenin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antivenin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Antivenin Market Overview
1.1 Product Overview and Scope of Antivenin
1.2 Antivenin Segment by Type
1.2.1 Global Antivenin Market Value Comparison by Type (2024-2030)
1.2.2 Polyvalent
1.2.3 Monovalent
1.3 Antivenin Segment by Application
1.3.1 Global Antivenin Market Value by Application: (2024-2030)
1.3.2 Hospitals and Clinics
1.3.3 Non-profit Institutions
1.4 Global Antivenin Market Size Estimates and Forecasts
1.4.1 Global Antivenin Revenue 2019-2030
1.4.2 Global Antivenin Sales 2019-2030
1.4.3 Global Antivenin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Antivenin Market Competition by Manufacturers
2.1 Global Antivenin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Antivenin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Antivenin Average Price by Manufacturers (2019-2024)
2.4 Global Antivenin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antivenin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antivenin, Product Type & Application
2.7 Antivenin Market Competitive Situation and Trends
2.7.1 Antivenin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antivenin Players Market Share by Revenue
2.7.3 Global Antivenin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antivenin Retrospective Market Scenario by Region
3.1 Global Antivenin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Antivenin Global Antivenin Sales by Region: 2019-2030
3.2.1 Global Antivenin Sales by Region: 2019-2024
3.2.2 Global Antivenin Sales by Region: 2025-2030
3.3 Global Antivenin Global Antivenin Revenue by Region: 2019-2030
3.3.1 Global Antivenin Revenue by Region: 2019-2024
3.3.2 Global Antivenin Revenue by Region: 2025-2030
3.4 North America Antivenin Market Facts & Figures by Country
3.4.1 North America Antivenin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Antivenin Sales by Country (2019-2030)
3.4.3 North America Antivenin Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antivenin Market Facts & Figures by Country
3.5.1 Europe Antivenin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Antivenin Sales by Country (2019-2030)
3.5.3 Europe Antivenin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antivenin Market Facts & Figures by Country
3.6.1 Asia Pacific Antivenin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Antivenin Sales by Country (2019-2030)
3.6.3 Asia Pacific Antivenin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Antivenin Market Facts & Figures by Country
3.7.1 Latin America Antivenin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Antivenin Sales by Country (2019-2030)
3.7.3 Latin America Antivenin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antivenin Market Facts & Figures by Country
3.8.1 Middle East and Africa Antivenin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Antivenin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Antivenin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antivenin Sales by Type (2019-2030)
4.1.1 Global Antivenin Sales by Type (2019-2024)
4.1.2 Global Antivenin Sales by Type (2025-2030)
4.1.3 Global Antivenin Sales Market Share by Type (2019-2030)
4.2 Global Antivenin Revenue by Type (2019-2030)
4.2.1 Global Antivenin Revenue by Type (2019-2024)
4.2.2 Global Antivenin Revenue by Type (2025-2030)
4.2.3 Global Antivenin Revenue Market Share by Type (2019-2030)
4.3 Global Antivenin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Antivenin Sales by Application (2019-2030)
5.1.1 Global Antivenin Sales by Application (2019-2024)
5.1.2 Global Antivenin Sales by Application (2025-2030)
5.1.3 Global Antivenin Sales Market Share by Application (2019-2030)
5.2 Global Antivenin Revenue by Application (2019-2030)
5.2.1 Global Antivenin Revenue by Application (2019-2024)
5.2.2 Global Antivenin Revenue by Application (2025-2030)
5.2.3 Global Antivenin Revenue Market Share by Application (2019-2030)
5.3 Global Antivenin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 CSL
6.1.1 CSL Corporation Information
6.1.2 CSL Description and Business Overview
6.1.3 CSL Antivenin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CSL Antivenin Product Portfolio
6.1.5 CSL Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Antivenin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Antivenin Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 BTG
6.3.1 BTG Corporation Information
6.3.2 BTG Description and Business Overview
6.3.3 BTG Antivenin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BTG Antivenin Product Portfolio
6.3.5 BTG Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Antivenin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Antivenin Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Haffkine Bio-Pharmaceutical
6.5.1 Haffkine Bio-Pharmaceutical Corporation Information
6.5.2 Haffkine Bio-Pharmaceutical Description and Business Overview
6.5.3 Haffkine Bio-Pharmaceutical Antivenin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Haffkine Bio-Pharmaceutical Antivenin Product Portfolio
6.5.5 Haffkine Bio-Pharmaceutical Recent Developments/Updates
6.6 Rare Disease Therapeutics
6.6.1 Rare Disease Therapeutics Corporation Information
6.6.2 Rare Disease Therapeutics Description and Business Overview
6.6.3 Rare Disease Therapeutics Antivenin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Rare Disease Therapeutics Antivenin Product Portfolio
6.6.5 Rare Disease Therapeutics Recent Developments/Updates
6.7 Flynn Pharma
6.6.1 Flynn Pharma Corporation Information
6.6.2 Flynn Pharma Description and Business Overview
6.6.3 Flynn Pharma Antivenin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Flynn Pharma Antivenin Product Portfolio
6.7.5 Flynn Pharma Recent Developments/Updates
6.8 Vins Bioproducts
6.8.1 Vins Bioproducts Corporation Information
6.8.2 Vins Bioproducts Description and Business Overview
6.8.3 Vins Bioproducts Antivenin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Vins Bioproducts Antivenin Product Portfolio
6.8.5 Vins Bioproducts Recent Developments/Updates
6.9 Bharat Serums and Vaccines
6.9.1 Bharat Serums and Vaccines Corporation Information
6.9.2 Bharat Serums and Vaccines Description and Business Overview
6.9.3 Bharat Serums and Vaccines Antivenin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bharat Serums and Vaccines Antivenin Product Portfolio
6.9.5 Bharat Serums and Vaccines Recent Developments/Updates
6.10 Serum Biotech
6.10.1 Serum Biotech Corporation Information
6.10.2 Serum Biotech Description and Business Overview
6.10.3 Serum Biotech Antivenin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Serum Biotech Antivenin Product Portfolio
6.10.5 Serum Biotech Recent Developments/Updates
6.11 MicroPharm
6.11.1 MicroPharm Corporation Information
6.11.2 MicroPharm Antivenin Description and Business Overview
6.11.3 MicroPharm Antivenin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 MicroPharm Antivenin Product Portfolio
6.11.5 MicroPharm Recent Developments/Updates
6.12 CSL
6.12.1 CSL Corporation Information
6.12.2 CSL Antivenin Description and Business Overview
6.12.3 CSL Antivenin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 CSL Antivenin Product Portfolio
6.12.5 CSL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antivenin Industry Chain Analysis
7.2 Antivenin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antivenin Production Mode & Process
7.4 Antivenin Sales and Marketing
7.4.1 Antivenin Sales Channels
7.4.2 Antivenin Distributors
7.5 Antivenin Customers
8 Antivenin Market Dynamics
8.1 Antivenin Industry Trends
8.2 Antivenin Market Drivers
8.3 Antivenin Market Challenges
8.4 Antivenin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
